Abcellera biologics inc.

Major-Pharmaceuticals

ABCL


2215 Yukon Street
Vancouver , BC V5Y 0A1

Executive/
Director

Price

  • Last Close
  • $ 3.12
    $ +0.1 3.31 %
    Jan 3, 2025
  • 52-Week High/Low
  • $5.97 - $2.5
  • YTD
  • 6.3%

  • Trading Volume
  • 51,754
  • Market Cap Full
  • $ 0.9B
  • Shares Outstanding
  • 290.2M
    Oct 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -13.3% -31.8% -25.6% -20.7% 6.3%
Q2 - - - - 4% -35.2% 9.2% -14.3% -14.1% -
Q3 - - - - 8% -9.8% -7.1% -28.8% -21.4% -
Q4 - - - - -33.5% -28% 2.4% 28% -0.5% -
J F M A M J J A S O N D
2025 6.3% - - - - - - - - - - -
2024 -10.5% -1.2% -10.3% -15.7% - - - -21.4% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-63%-29%-44%-49%6%

Earnings

2019 2020 2021 2022 2023
Q1 - - 0.37 0.54 -0.14
Q2 - - -0.01 -0.02 -0.11
Q3 - - -0.08 0.08 -0.10
Q4 - - 0.2 -0.10 -
A -0 0.5 0.5 0.5 -0.35

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 283.9 287.7
Jun 270.9 284.5 288.7
Sep 278.7 285.1 289.4
Dec 281.6 286.1 290.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 1.4 1.9 5.2 1.2 -
Total Asset Turnover 0.3 0.3 0.2 0.5 -
Leverage
Debt Ratio - - - 0.1 -
Debt – Equity Ratio - - - 0.1 -
Interest Coverage 3.7 4 4.2 2 1
Equity multiplier 0.3 0.2 0.1 1 -